Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Salud Mental (24)

2025

  1. Clozapine pharmacovigilance in Croatia: Underreporting of specific adverse drug reactions and excellent reporting of suicide attempts: Clozapine Croatia suicide

    Psychiatry Research, Vol. 347

  2. Heterogeneity of morphometric similarity networks in health and schizophrenia

    Schizophrenia, Vol. 11, Núm. 1

  3. Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I A Review of the Pharmacokinetic Literature and Proposed Changes

    Journal of Clinical Psychopharmacology, Vol. 45, Núm. 3, pp. 179-196

2024

  1. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

    Schizophrenia Research, Vol. 268, pp. 165-174

  2. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

    Schizophrenia Research, Vol. 268, pp. 53-59

  3. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

    Schizophrenia Research, Vol. 268, pp. 60-65

  4. Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

    Expert Opinion on Drug Safety

  5. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

    Schizophrenia Research, Vol. 268, pp. 118-130

  6. Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data

    European Child and Adolescent Psychiatry

  7. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies

    Schizophrenia Research, Vol. 268, pp. 293-301

  8. Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 20, Núm. 8, pp. 857-871

  9. Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

    Patient Preference and Adherence , Vol. 18, pp. 2261-2280

  10. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

    Schizophrenia Research, Vol. 268, pp. 175-188

2023

  1. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom

    Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245

  2. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 19, Núm. 2, pp. 57-74

2022

  1. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 18, Núm. 11, pp. 715-727

  2. Promoting safer clozapine dosing in the Americas

    Brazilian Journal of Psychiatry

2018

  1. Comparisons of schizotypal traits across 12 countries: Results from the International Consortium for Schizotypy Research

    Schizophrenia Research

  2. Predictive validity of the Sidorkiewicz instrument in Spanish: assessing individual drug adherence in psychiatric patients

    International journal of clinical and health psychology, Vol. 18, Núm. 2, pp. 133-142

  3. The Network Structure of Schizotypal Personality Traits

    Schizophrenia Bulletin, Vol. 44, pp. S468-S479